3-(Cyclobutylmethoxy)pyridine-2-carboxylic acid, 1g

4,4,5,5-Tetramethyl-2-(2-methyl-3-thienyl)-1,3,2-dioxaborolane, 95.0%, 1g

5-BROMO-3-METHOXY-1H-PYRAZOLE, 95.0%, 50mg

(S)-Ethyl 3-(2-chlorophenyl)butanoate, 97%, 1g

9-(2-Ethylhexyl)-3,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole>98.0%(HPLC)(T)1g

Methyldiphenylsilane>95.0%(GC)25mL

2-Chloro-7,8-dihydroquinolin-5(6H)-one, 95.0%, 1g

tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate, 95.0%, 1g

2,7-Dibromo-9-(4-bromophenyl)-9H-carbazole, 97%, 250mg

Single-channel microliter pipette mLINE® variable, 0.1 to 3 µl, 1 piece

(-)-4,5-Bis[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolane>97.0%(HPLC)1g

Tyrphostin A1>98.0%(GC)200mg

3-(3-Fluorophenyl)-propionitrile, 95.0%, 5g